Interventions to improve linkage along the HIV-tuberculosis care cascades in low- and middle-income countries: A systematic review and meta-analysis.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 22 12 2021
accepted: 09 04 2022
entrez: 13 5 2022
pubmed: 14 5 2022
medline: 18 5 2022
Statut: epublish

Résumé

In support of global targets to end HIV/AIDS and tuberculosis (TB) by 2030, we reviewed interventions aiming to improve TB case-detection and anti-TB treatment among people living with HIV (PLHIV) and HIV testing and antiretroviral treatment initiation among people with TB disease in low- and middle-income countries (LMICs). We conducted a systematic review of comparative (quasi-)experimental interventional studies published in Medline or EMBASE between January 2003-July 2021. We performed random-effects effect meta-analyses (DerSimonian and Laird method) for interventions that were homogenous (based on intervention descriptions); for others we narratively synthesized the intervention effect. Studies were assessed using ROBINS-I, Cochrane Risk-of-Bias, and GRADE. (PROSPERO #CRD42018109629). Of 21,516 retrieved studies, 23 were included, contributing 53 arms and 84,884 participants from 4 continents. Five interventions were analyzed: co-location of test and/or treatment services; patient education and counselling; dedicated personnel; peer support; and financial support. A majority were implemented in primary health facilities (n = 22) and reported on HIV outcomes in people with TB (n = 18). Service co-location had the most consistent positive effect on HIV testing and treatment initiation among people with TB, and TB case-detection among PLHIV. Other interventions were heterogenous, implemented concurrent with standard-of-care strategies and/or diverse facility-level improvements, and produced mixed effects. Operational system, human resource, and/or laboratory strengthening were common within successful interventions. Most studies had a moderate to serious risk of bias. This review provides operational clarity on intervention models that can support early linkages between the TB and HIV care cascades. The findings have supported the World Health Organization 2020 HIV Service Delivery Guidelines update. Further research is needed to evaluate the distinct effect of education and counselling, financial support, and dedicated personnel interventions, and to explore the role of community-based, virtual, and differentiated service delivery models in addressing TB-HIV co-morbidity.

Identifiants

pubmed: 35552547
doi: 10.1371/journal.pone.0267511
pii: PONE-D-21-39116
pmc: PMC9098064
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article Meta-Analysis Systematic Review Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0267511

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Déclaration de conflit d'intérêts

We have read the journal’s policy and the authors of this manuscript have the following competing interests: AD is a member of the Editorial Board of PLOS ONE. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The remaining authors have declared that no competing interests exist. The opinions expressed in the manuscript are those of the authors alone. They do not purport to reflect the opinions or views of the World Health Organization, or The Global Fund to Fight AIDS, Tuberculosis and Malaria, or its members.

Références

Contemp Clin Trials. 2018 Sep;72:43-52
pubmed: 30053431
Curr HIV/AIDS Rep. 2019 Aug;16(4):324-334
pubmed: 31230342
EClinicalMedicine. 2020 Oct 24;28:100603
pubmed: 33134905
AIDS Behav. 2014 Oct;18 Suppl 5:S531-41
pubmed: 24619602
Nature. 2015 Dec 3;528(7580):S77-85
pubmed: 26633769
Trop Med Int Health. 2011 Apr;16(4):431-8
pubmed: 21255204
Eur Respir J. 2018 Jan 11;51(1):
pubmed: 29326332
J Infect Dis. 2007 Aug 15;196 Suppl 1:S1-3
pubmed: 17624818
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Trans R Soc Trop Med Hyg. 2014 Sep;108(9):560-7
pubmed: 25059522
Int J Tuberc Lung Dis. 2013 Oct;17(10 Suppl 1):48-55
pubmed: 24020602
Public Health Action. 2016 Dec 21;6(4):252-254
pubmed: 28123963
Int J Tuberc Lung Dis. 2008 Aug;12(8):955-61
pubmed: 18647457
AIDS Care. 2018 Dec;30(12):1600-1604
pubmed: 30021448
Int J Tuberc Lung Dis. 2012 Aug;16(8):1052-8
pubmed: 22691870
Curr Opin Infect Dis. 2020 Feb;33(1):44-50
pubmed: 31789695
PLoS One. 2018 Apr 10;13(4):e0194960
pubmed: 29634772
PLoS One. 2012;7(10):e46988
pubmed: 23071690
Lancet Respir Med. 2018 Apr;6(4):299-314
pubmed: 29595511
Cochrane Database Syst Rev. 2017 Nov 28;11:CD011432
pubmed: 29182800
Int J Tuberc Lung Dis. 2019 Jul 1;23(7):811-816
pubmed: 31439112
Public Health Action. 2020 Mar 21;10(1):11-16
pubmed: 32368518
Int J Tuberc Lung Dis. 2010 May;14(5):611-5
pubmed: 20392355
Drug Alcohol Depend. 2013 May 1;129(3):180-209
pubmed: 23306095
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
BMC Med. 2020 Feb 11;18(1):19
pubmed: 32041583
Int J Tuberc Lung Dis. 2008 Mar;12(3 Suppl 1):73-8
pubmed: 18302827
J Int AIDS Soc. 2018 Jan;21(1):
pubmed: 29381257
Int J Tuberc Lung Dis. 2008 Mar;12(3 Suppl 1):44-50
pubmed: 18302822
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Int J Tuberc Lung Dis. 2016 Sep;20(9):1185-91
pubmed: 27510244
J Int AIDS Soc. 2016 Dec 01;19(1):21484
pubmed: 27914186
Trop Med Int Health. 2013 Feb;18(2):199-211
pubmed: 23217030
Lancet Infect Dis. 2011 Nov;11(11):855-67
pubmed: 22035614
Int J Tuberc Lung Dis. 2011 Jun;15 Suppl 2:50-57
pubmed: 21740659
J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):e29-35
pubmed: 22395671
AIDS Care. 2013;25(5):525-43
pubmed: 22880845
MMWR Morb Mortal Wkly Rep. 2008 Mar 21;57(11):285-9
pubmed: 18354372
J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):e110-7
pubmed: 24091692
AIDS Behav. 2014 Jan;18 Suppl 1:S96-103
pubmed: 23959143
BMC Infect Dis. 2018 Oct 26;18(1):536
pubmed: 30367622
BMC Public Health. 2012 Aug 20;12:674
pubmed: 22905704
BMC Infect Dis. 2013 Aug 26;13:390
pubmed: 23972276
Public Health Action. 2015 Mar 21;5(1):36-44
pubmed: 26400600
BMJ. 2020 Jan 16;368:l6890
pubmed: 31948937
Clin Infect Dis. 2010 May 15;50 Suppl 3:S238-44
pubmed: 20397954

Auteurs

Angela Salomon (A)

School of Medicine, Queen's University, Kingston, Canada.
McGill International TB Centre, Research Institute of the McGill University Health Centre, Montréal, Canada.

Stephanie Law (S)

McGill International TB Centre, Research Institute of the McGill University Health Centre, Montréal, Canada.

Cheryl Johnson (C)

Global HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland.

Annabel Baddeley (A)

Global TB Programme, World Health Organization, Geneva, Switzerland.

Ajay Rangaraj (A)

Global HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland.

Satvinder Singh (S)

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.

Amrita Daftary (A)

School of Global Health and Dahdaleh Institute of Global Health Research, York University, Toronto, Canada.
Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH